Innovative medicines in the pipeline
Only 5 % of rare diseases have approved medicines. The need for innovative treatments is, therefore, high. A strong pipeline and expanded access are key elements of our commitment to patients.
Interim Report Q1 2025
Sobi published Q1 2025 report on 29 April.
Annual General Meeting 2025
The AGM was held on Thursday, 8 May 2025.
Press releases
A new therapy’s path to the patient
Bringing new therapies to patients involves navigating long timelines and inherent risks, making it a complex and costly endeavor. Discover how we prioritise patient access to treatment while addressing these development challenges.
Focus on Rare diseases
More than 10,000 rare diseases have been identified, with more being discovered every day. While many rare diseases are very uncommon, together they affect 400 million people worldwide.
Our stories
At Sobi, we are dedicated to transforming the lives of people with rare and debilitating diseases. Meet some of the people who inspire us.
Their real-life experiences and stories reinforce our commitment to patients.
Head office
Careers
Take a look at our job opportunities.